APA (7th ed.) Citation

O, L., M, C., LB, L. N., L, N., M, L., I, B. G., . . . X, d. L. (2022). Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine. The New England journal of medicine, 387(4), 374. https://doi.org/10.1056/NEJMc2206711

Chicago Style (17th ed.) Citation

O, Launay, et al. "Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine." The New England Journal of Medicine 387, no. 4 (2022): 374. https://doi.org/10.1056/NEJMc2206711.

MLA (9th ed.) Citation

O, Launay, et al. "Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine." The New England Journal of Medicine, vol. 387, no. 4, 2022, p. 374, https://doi.org/10.1056/NEJMc2206711.